Europe — EMA

Ondansetron Accord

Ondansetron, the active ingredient in Ondansetron Accord, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy…

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

GNH USA supplies Ondansetron Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron Accord acts on the serotonergic pathway that contributes to nausea and vomiting. It is used in several clinical situations: - Chemotherapy‑induced nausea and vomiting (CINV): It makes the … - Radiotherapy induced N/V : … .... - Post‑ .... - .... - ....

What are the side effects of Ondansetron?

The ...

What precautions apply to Ondansetron?

The …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →